Partnering to harmonise clinical data
Genomic data management and analytics company BC Platforms AG has announced that it is partnering with Medaffcon Oy, which generates real-world evidence for health-related decision making. The companies said that the partnership is focusing on harmonising complex genomic and clinical data from multiple sources, applying joint specialist knowledge and technological capabilities.
BC Platforms has more than 20 years’ experience in working with genomics and information technology. During this time, it has built a global network of biobanks that provide a safe and secure environment for biobanks and researchers to determine data availability and advance research. Medaffcon has core competences in scientific and health economic expertise and has also been pioneering industry-driven biobank research efforts, since the establishment of the first biobanks in Finland. It is owned by the PHOENIX group, a large integrated European healthcare provider ensuring that patients and the public have access to high-quality healthcare across Europe.
"We are very excited to be partnering with BC Platforms and their world leading network of biobanks through their BCRQUEST service. The collaboration will expand our capabilities of accessing and combining different Finnish and international data sources to advance research,” said Jaana Ahlamaa, Medical and Market Access Director at Medaffcon.
Tero Silvola, CEO of BC Platforms, said: “We are delighted to partner with Medaffcon, part of the PHOENIX group. Our goal is to combine our global platform to leverage Medaffcon´s extensive expertise in key markets in order to utilise real-world evidence faster and more effectively.”